Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Deep grey matter MRI abnormalities and cognitive function in relapsing-remitting multiple sclerosis.
Postoperative cystoid macular oedema in a patient on fingolimod.
Quantitative magnetic resonance imaging of cortical multiple sclerosis pathology.
Hypercalcaemia and acute kidney injury following administration of vitamin D in granulomatous disease.
Neurological involvement in primary sjögren syndrome: a focus on central nervous system.
Localized grey matter atrophy in multiple sclerosis: A meta-analysis of voxel-based morphometry studies and associations with functional disability.
Month of birth is not a definite risk factor for multiple sclerosis.
Quantitative MRI demonstrates abnormality of the fornix and cingulum in multiple sclerosis.
Vitamin D levels in multiple sclerosis patients: Association with TGF-β2, TGF-βRI, and TGF-βRII expression.
Stratification and monitoring of natalizumab-associated progressive multifocal leukoencephalopathy risk: recommendations from an expert group.
Regulation of DM-20 mRNA expression and intracellular translocation of glutathione-S-transferase pi isoform during oligodendrocyte differentiation in the adult rat spinal cord.
Impaired social cognition in multiple sclerosis.
Mycophenolate mofetil in combination with interferon beta-1a in the treatment of relapsing-remitting multiple sclerosis: A preliminary study.
Oxidised LDL lipids, statins and a blood-brain barrier.
Ophthalmic manifestations of systemic diseases-part 2: metabolic, infections, granulomatoses, demyelination, and skeletal dysplasias.
MS nurses join project to prove the value of specialist role.
Concise review: Stem cell trials using companion animal disease models.
Benign Multiple Sclerosis is Associated with Reduced Thinning of the Retinal Nerve Fiber and Ganglion Cell Layers in Non-Optic-Neuritis Eyes.
X-linked Charcot-Marie-Tooth disease type 6 (CMTX6) patients with a p.R158H mutation in the pyruvate dehydrogenase kinase isoenzyme 3 gene.
Human vaccines & immunotherapeutics: news.
Regulatory dendritic cell therapy: From rodents to clinical application.
B cells in MS and NMO: pathogenesis and therapy.
Author response.
Impact of mobility impairment on indirect costs and health-related quality of life in multiple sclerosis.
Multiple sclerosis patients have a diminished serologic response to vitamin D supplementation compared to healthy controls.
Pages
« first
‹ previous
…
478
479
480
481
482
483
484
485
486
…
next ›
last »